ABCL Stock Forecast & Price Target
ABCL Stock
Price Forecast
The average stock forecast for
Abcellera Biologics Inc (ABCL) in the next 12 months is 17.47 USD. This price target corresponds to an upside
of
50.97%. The range of stock forecasts for ABCL is 9.09 - 31.50 USD.
Based on the ratings of 15 analysts, the consensus recommendation for ABCL is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
9.09 |
17.47 |
15.30 |
31.50 |
| Upside |
-21.43% |
50.97% |
32.24% |
172.26% |
Recommendation Trends
The latest consensus rating for ABCL is "BUY". This is the average
recommendation of 15 analysts: 0 strong sell,
0 sell, 1 hold, 11 buy, 3 strong buy. In the previous period, 15 analysts also majorly recommmended
"BUY" for ABCL.
ABCL Financial Stock
Forecast
Revenue This Year
from 75.13M
Revenue Next Year
from 25.86M